In January 2023, Avecho announced that New York-based global biopharmaceutical company Athenex had submitted Avecho’s TPM®-enhanced phytonadione injectable product to the FDA for feedback via a preIND meeting request. FDA feedback will determine the remaining development work required to support a future product registration.
..cant wait to get the results from above....! we'll soon forget about cash raising
In January 2023, Avecho announced that New York-based global...
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $1.801K | 512.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 36 | 94441246 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 20308827 | 11 |
View Market Depth
| Last trade - 15.46pm 06/05/2024 (20 minute delay) ? |
| AVE (ASX) Chart |